Chuka Nwokolo
Chuka Nwokolo
Professor of Gastroenterology, Warwick Medical School
Verified email at uhcw.nhs.uk
Title
Cited by
Cited by
Year
Plasma ghrelin following cure of Helicobacter pylori
CU Nwokolo, DA Freshwater, P O’hare, HS Randeva
Gut 52 (5), 637-640, 2003
2862003
Inappropriate hypergastrinaemia in asymptomatic healthy subjects infected with Helicobacter pylori.
JT Smith, RE Pounder, CU Nwokolo, S Lanzon-Miller, DG Evans, ...
Gut 31 (5), 522-525, 1990
2281990
Common variants at the MHC locus and at chromosome 16q24. 1 predispose to Barrett's esophagus
Z Su, LJ Gay, A Strange, C Palles, G Band, DC Whiteman, F Lescai, ...
Nature genetics 44 (10), 1131-1136, 2012
1642012
Predictors of anti-TNF treatment failure in anti-TNF-naive patients with active luminal Crohn's disease: a prospective, multicentre, cohort study
NA Kennedy, GA Heap, HD Green, B Hamilton, C Bewshea, GJ Walker, ...
The lancet Gastroenterology & hepatology 4 (5), 341-353, 2019
1602019
Tolerance during 29 days of conventional dosing with cimetidine, nizatidine, famotidine or ranitidine.
CU Nwokolo, JT Smith, C Gavey, A Sawyerr, RE Pounder
Alimentary pharmacology & therapeutics 4, 29-45, 1990
1491990
Detection of colorectal cancer (CRC) by urinary volatile organic compound analysis
RP Arasaradnam, MJ McFarlane, C Ryan-Fisher, E Westenbrink, ...
PloS one 9 (9), e108750, 2014
1142014
Development and application of a new electronic nose instrument for the detection of colorectal cancer
E Westenbrink, RP Arasaradnam, N O'Connell, C Bailey, C Nwokolo, ...
Biosensors and Bioelectronics 67, 733-738, 2015
1022015
Next generation diagnostic modalities in gastroenterology–gas phase volatile compound biomarker detection
RP Arasaradnam, JA Covington, C Harmston, CU Nwokolo
Alimentary pharmacology & therapeutics 39 (8), 780-789, 2014
1002014
Eradication of Helicobacter pylori abolishes 24‐hour hypergastrinaemia: a prospective study in healthy subjects
EJ Prewett, JTL Smith, CU Nwokolo, M Hudson, AM Sawyerr, RE Pounder
Alimentary pharmacology & therapeutics 5 (3), 283-290, 1991
861991
Polymorphisms near TBX5 and GDF7 are associated with increased risk for Barrett’s esophagus
C Palles, L Chegwidden, X Li, JM Findlay, G Farnham, FC Giner, ...
Gastroenterology 148 (2), 367-378, 2015
842015
Rebound intragastric hyperacidity after abrupt withdrawal of histamine H2 receptor blockade.
CU Nwokolo, JT Smith, AM Sawyerr, RE Pounder
Gut 32 (12), 1455-1460, 1991
831991
Utility of faecal calprotectin in inflammatory bowel disease (IBD): what cut-offs should we apply?
A Dhaliwal, Z Zeino, C Tomkins, M Cheung, C Nwokolo, S Smith, ...
Frontline Gastroenterology 6 (1), 14-19, 2015
792015
Ciprofloxacin suppresses bacterial overgrowth, increases fasting insulin but does not correct low acylated ghrelin concentration in non‐alcoholic steatohepatitis
A Sajjad, M Mottershead, WK Syn, R Jones, S Smith, CU Nwokolo
Alimentary pharmacology & therapeutics 22 (4), 291-299, 2005
772005
Tolerance during 8 days of high-dose H2-blockade: placebo-controlled studies of 24-hour acidity and gastrin.
JT Smith, C Gavey, CU Nwokolo, RE Pounder
Alimentary pharmacology & therapeutics 4, 47-63, 1990
761990
Mercaptopurine versus placebo to prevent recurrence of Crohn's disease after surgical resection (TOPPIC): a multicentre, double-blind, randomised controlled trial
C Mowat, I Arnott, A Cahill, M Smith, T Ahmad, S Subramanian, S Travis, ...
The lancet Gastroenterology & hepatology 1 (4), 273-282, 2016
752016
Surgical resections in parous patients with distal ileal and colonic Crohn's disease.
CU Nwokolo, WC Tan, HA Andrews, RN Allan
Gut 35 (2), 220-223, 1994
751994
Bismuth accumulates in the body during treatment with tripotassium dicitrato bismuthate
CJ Gavey, ML Szeto, CU Nwokolo, J Sercombe, RE Pounder
Alimentary pharmacology & therapeutics 3 (1), 21-28, 1989
751989
A novel tool for noninvasive diagnosis and tracking of patients with inflammatory bowel disease
RP Arasaradnam, N Ouaret, MG Thomas, N Quraishi, E Heatherington, ...
Inflammatory bowel diseases 19 (5), 999-1003, 2013
742013
The absorption of bismuth from oral doses of tripotassium dicitrato bismuthate
CU Nwokolo, CJ Gavey, JTL Smith, RE Pounder
Alimentary pharmacology & therapeutics 3 (1), 29-39, 1989
741989
Diagnostic accuracy of faecal biomarkers in detecting colorectal cancer and adenoma in symptomatic patients
MM Widlak, CL Thomas, MG Thomas, C Tomkins, S Smith, N O'Connell, ...
Alimentary pharmacology & therapeutics 45 (2), 354-363, 2017
692017
The system can't perform the operation now. Try again later.
Articles 1–20